Therapeutic Potentials of Microalgae in the Treatment of Alzheimer’s Disease
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Current research is geared towards the discovery of new compounds with strong neuroprotective potential and few or no side effects compared to synthetic drugs. This review focuses on the potentials of extracts and biologically active compounds derived from microalgal biomass for the treatment and management of Alzheimer’s disease (AD). Microalgal research has gained much attention recently due to its contribution to the production of renewable fuels and the ability of alga cells to produce several secondary metabolites such as carotenoids, polyphenols, sterols, polyunsaturated fatty acids and polysaccharides. These compounds exhibit several pharmacological activities and possess neuroprotective potential. The pathogenesis of Alzheimer’s disease (AD) involves complex mechanisms that are associated with oxidative stress, cholinergic dysfunction, neuronal damage, protein misfolding and aggregation. The antioxidant, anticholinesterase activities as well as the inhibitory effects of some bioactive compounds from microalgae extracts on β-amyloid aggregation and neuronal death are discussed extensively. Phytochemical compounds from microalgae are used as pharmaceuticals, nutraceuticals and food supplements, and may possess neuroprotective potentials that are relevant to the management and/or treatment of AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Commercial Applications of Microalgae
Spolaore, P., Joannis-Cassan, C., Duran, E., & Isambert, A. (2006) · Journal of Bioscience and Bioengineering · doi:10.1263/jbb.101.87 · Cited by 4,285
Uttara, B., Singh, A., Zamboni, P., & Mahajan, R. (2009) · Current Neuropharmacology · doi:10.2174/157015909787602823 · Cited by 3,378 · cited 1×
“Brain cells are predisposed to free radical attack due to their high lipid content, low levels of antioxidant enzymes and the inability of their neurons to synthesize glutathione [4,99].”
BackgroundNeuropathological alterations in Alzheimer disease
Serrano-Pozo, A., Frosch, M. P., Masliah, E., & Hyman, B. T. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006189 · Cited by 3,345 · cited 2×
“Overproduction of β-amyloid triggers the misfolding of proteins that is observed in the AD brain which include β-amyloid aggregation, formation of senile plaques and neurofibrillary tangles around the neurons [139].”
BackgroundAcetylcholinesterase Inhibitors: Pharmacology and Toxicology
Colovic, M. B., Krstic, D. Z., Lazarevic-Pasti, T. D., Bondzic, A. M., & Vasic, V. M. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311030006 · Cited by 2,611
Amyloid Precursor Protein Processing and Alzheimer's Disease
O'Brien, R. J., & Wong, P. C. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113613 · Cited by 2,061 · cited 10×
“Currently, some synthetic BACE-1 inhibitors are under clinical trials [7].”
BackgroundInfluentialDyall, S. C. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00052 · Cited by 943
Microalgal biofactories: A promising approach towards sustainable omega-3 fatty acid production
Adarme-Vega, T. C., Lim, D. K. Y., Timmins, M., Vernen, F., Li, Y., & Schenk, P. M. (2012) · Microbial Cell Factories · doi:10.1186/1475-2859-11-96 · Cited by 641 · cited 1×
“Microalgae are an excellent reservoir of omega-3 PUFA [68].”
BackgroundMicroalgae as sources of carotenoids
Guedes, A. C., Amaro, H. M., & Malcata, F. X. (2011) · Marine Drugs · doi:10.3390/md9040625 · Cited by 639 · cited 9×
“Crypthecodinium cohnii is predominantly rich in DHA producing up to 40–50% with the absence of EPA [70].”
BackgroundInfluentialThe Alzheimer's disease Beta-secretase enzyme, BACE1
Cole, S. L., & Vassar, R. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-22 · Cited by 550
Safafar, H., Van Wagenen, J., Møller, P., & Jacobsen, C. (2015) · Marine Drugs · doi:10.3390/md13127069 · Cited by 478
Cited by
Microalgae: A Promising Source of Valuable Bioproducts
Dolganyuk, V., Belova, D., Babich, O., Prosekov, A., Ivanova, S., Katserov, D., Patyukov, N., & Sukhikh, S. (2020) · Biomolecules · doi:10.3390/biom10081153 · Cited by 481
Potential utilization of bioproducts from microalgae for the quality enhancement of natural products
Tang, D. Y. Y., Khoo, K. S., Chew, K. W., Tao, Y., Ho, S.-H., & Show, P. L. (2020) · Bioresource Technology · doi:10.1016/j.biortech.2020.122997 · Cited by 390
Fabris, M., Abbriano, R. M., Pernice, M., Sutherland, D. L., Commault, A. S., Hall, C. C., Labeeuw, L., McCauley, J. I., Kuzhiuparambil, U., Ray, P., et al. (2020) · Frontiers in Plant Science · doi:10.3389/fpls.2020.00279 · Cited by 382
Applications of Phyto-Nanotechnology for the Treatment of Neurodegenerative Disorders
Bhattacharya, T., Soares, G. A. B. E., Chopra, H., Rahman, M. M., Hasan, Z., Swain, S. S., & Cavalu, S. (2022) · Materials · doi:10.3390/ma15030804 · Cited by 259
Mutanda, T., Naidoo, D., Bwapwa, J. K., & Anandraj, A. (2020) · Frontiers in Energy Research · doi:10.3389/fenrg.2020.598803 · Cited by 160
Microalgal Cell Biofactory—Therapeutic, Nutraceutical and Functional Food Applications
Kiran, B. R., & Venkata Mohan, S. (2021) · Plants · doi:10.3390/plants10050836 · Cited by 124
“They include bioflavonoids, carotenoids, vitamins (C and E), biometals, and omega-3 and omega6 fatty acids [73].”
BackgroundAmato, A., Terzo, S., & Mulè, F. (2019) · Antioxidants · doi:10.3390/antiox8120608 · Cited by 107
“Another class of natural compounds with strong neuroprotective potential and which is relatively unexplored yet is represented by extracts and biologically active compounds derived from microalgal biomass [123].”
BackgroundMatin, M., Koszarska, M., Atanasov, A. G., Król-Szmajda, K., Jóźwik, A., Stelmasiak, A., & Hejna, M. (2024) · Molecules · doi:10.3390/molecules29194695 · Cited by 104
Antioxidants from microalgae and their potential impact on human well-being
Pereira, L., Cotas, J., & Valado, A. (2024) · Exploration of Drug Science · doi:10.37349/eds.2024.00048 · Cited by 48
Dimopoulou, M., Kolonas, A., Stagos, D., & Gortzi, O. (2025) · Biomass · doi:10.3390/biomass5010011 · Cited by 34
Dhandayuthapani, K., Malathy, S., Mulla, S. I., & Gupta, S. K. (2021) · Algae · doi:10.1007/978-981-15-7518-1_7 · Cited by 19
Metadata
- Authors
- Olasehinde, T., Olaniran, A., & Okoh, A.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2017-03-18
- Volume
- 22
- Issue
- 3
- Pages
- 480
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W2600438100
- Cited by
- 139
- References
- 30
- FWCI
- 12.96
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.